Evaluation of personal digital assistant software for drug interactions

American Journal of Health-System Pharmacy

Volumn 61, Issue 4, 2004, Pages 380-385

  Barrons, Robert ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

Computers; Drug interactions; Quality assurance

Indexed keywords

UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG CROSS REACTIVITY; HUMAN; INTERMETHOD COMPARISON; MINICOMPUTER; PERSONAL DIGITAL ASSISTANT; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; COMPARATIVE STUDY; DRUG INTERACTION; MEDICAL LITERATURE; MICROCOMPUTER; STANDARD; VALIDATION STUDY;

COMPUTERS, HANDHELD; DRUG INTERACTIONS; PHARMACOPOEIAS; SOFTWARE;

EID: 1642566572     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.4.380     Document Type: Article

References (12)

1. Weideman RA, Bernstein IH, McKinney WP. Pharmacist recognition of potential drug interactions. Am J Health-Syst Pharm. 1999; 56:1524-9.
2. Kraft KE, Dore FH. Computerized drug interaction programs: how reliable? JAMA. 1996; 275:1087. Letter.
3. Cavuto NJ, Woosley RI, Sale M. Pharmacies and prevention of potential fatal drug interactions. JAMA. 1996; 275:1086. Letter.
4. Hazlet TK, Lee TA, Hansten PD et al. Performance of community pharmacy drug interaction software. J Am Pharm Assoc. 2001; 41:200-4.
5. Gaddis GM, Holt TR, Woods M. Drug interactions in at-risk emergency department patients. Acad Emerg Med. 2002; 9:1162-7.
6. Strain JJ, Chiu NM, Brodsky K et al. Comparison of three methods for identifying medical drug-psychotropic drug interactions. Gen Hosp Psychiatry. 2002; 24:311-5.
7. Wolters Kluwer Health. Drug interaction facts on eFacts online. www. factsandcomparisons.com (accessed 2003 Jun and Jul).
8. Klasco RK, Moore L, eds. DRUG-REAX system. Greenwood Village, CO: Micromedex; edition expires 2003 Dec.
9. Hansten PD, Horn JR. Drug interactions analysis and management. A clinical perspective and analysis of current developments. St. Louis: Wolters Kluwer Health; 2003 Jul.
10. Hulley SB, Cummings SR, Browner WS. Designing clinical research: an epidemiologic approach. 2nd ed. Baltimore: Williams & Wilkins; 1998.
11. Hansten PD, Horn JR, Hazlet TK. ORCA: Operational classification of drug interactions. J Am Pharm Assoc. 2001; 41:161-5.
12. Kelly WN. Potential risks and prevention, part 4: reports of significant adverse drug events. Am J Health-Syst Pharm. 2001; 58(suppl):1406-12.